IOL Chemicals
NSE: IOLCP · Pharmaceuticals
Snapshot
Unlock IOL Chemicals's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
IOL Chemicals and Pharmaceuticals Limited is a manufacturer of active pharmaceutical ingredients (APIs) and specialty industrial chemicals. The company serves a diverse range of sectors including pharmaceuticals, food processing, textiles, and packaging.
Business Model
The company generates revenue through the large-scale production and sale of APIs, notably ibuprofen, and specialty chemicals such as ethyl acetate and iso butyl benzene. It operates as both a domestic supplier and an international exporter.
Growth Outlook
Growth is driven by the expansion of its API portfolio and the sustained demand for its specialty chemical intermediates across multiple industrial applications.
Key Risks
- Regulatory Compliance. The company faces stringent regulatory oversight from global health authorities, where non-compliance could lead to export restrictions.
- Raw Material Price Volatility. Fluctuations in the cost of chemical feedstocks and petrochemical derivatives can significantly impact profit margins.
- Currency Risk. As an exporter, the company is exposed to foreign exchange rate volatility which may affect its international competitiveness and earnings.
- Commodity Price Sensitivity. The specialty chemicals segment is susceptible to cyclical demand and price pressures within the global industrial chemical market.
Price
Start your research today
Unlock AI insights, financials, peers and live data on IOL Chemicals and 5,000+ companies — free.
Key Metrics
REVENUE
₹2,319 Cr
TTM · consolidated
NET PROFIT
₹138 Cr
TTM · consolidated
EPS
₹4.69
TTM · consolidated
RETURN ON EQUITY
8.0%
TTM · consolidated
RETURN ON CAPITAL EMPLOYED
11.0%
TTM · consolidated
P/E
35.0x
Q4 FY26 · consolidated
EV/EBITDA
16.8x
Q4 FY26 · consolidated
EBITDA MARGIN
12.5%
TTM · consolidated
NET PROFIT MARGIN
8.6%
Q4 FY26 · consolidated
DEBT TO EQUITY
0.1x
Q4 FY26 · consolidated
Peers · Pharmaceuticals
| Company | Mkt Cap (Cr) | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
IOL ChemicalsIOLCP | 2,287 | 34.98 | 16.82 | 11.5% | 12.5% | 8.0% | 11.0% | +75.6% |
Dishman Carbogen Amcis LimitedDCAL | 2,294 | 31.26 | 8.09 | 8.1% | 21.2% | 1.6% | 3.3% | -26.3% |
Novartis IndiaNOVARTIND | 2,266 | 42.28 | 29.45 | -0.5% | 37.5% | 11.7% | 16.1% | +51.3% |
Bliss GVS PharmaBLISSGVS | 2,193 | 41.29 | 22.41 | 14.5% | 25.6% | 12.4% | 17.4% | +219.3% |
Unichem Laboratories LimitedUNICHEMLAB | 2,111 | 16.84 | 18.17 | 8.5% | 11.1% | 10.0% | 12.2% | -6.3% |
Panacea BiotecPANACEABIO | 2,027 | -640.85 | 279.46 | 14.4% | 1.9% | -0.9% | -0.1% | +30.3% |
As of Q4 FY26
Financials
IOL Chemicals
NSE: IOLCP · Pharmaceuticals
Snapshot
Unlock IOL Chemicals's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
IOL Chemicals and Pharmaceuticals Limited is a manufacturer of active pharmaceutical ingredients (APIs) and specialty industrial chemicals. The company serves a diverse range of sectors including pharmaceuticals, food processing, textiles, and packaging.
Business Model
The company generates revenue through the large-scale production and sale of APIs, notably ibuprofen, and specialty chemicals such as ethyl acetate and iso butyl benzene. It operates as both a domestic supplier and an international exporter.
Growth Outlook
Growth is driven by the expansion of its API portfolio and the sustained demand for its specialty chemical intermediates across multiple industrial applications.
Key Risks
- Regulatory Compliance. The company faces stringent regulatory oversight from global health authorities, where non-compliance could lead to export restrictions.
- Raw Material Price Volatility. Fluctuations in the cost of chemical feedstocks and petrochemical derivatives can significantly impact profit margins.
- Currency Risk. As an exporter, the company is exposed to foreign exchange rate volatility which may affect its international competitiveness and earnings.
- Commodity Price Sensitivity. The specialty chemicals segment is susceptible to cyclical demand and price pressures within the global industrial chemical market.
Price
Loading…
Start your research today
Unlock AI insights, financials, peers and live data on IOL Chemicals and 5,000+ companies — free.
Key Metrics
REVENUE
₹2,319 Cr
TTM · consolidated
NET PROFIT
₹138 Cr
TTM · consolidated
EPS
₹4.69
TTM · consolidated
RETURN ON EQUITY
8.0%
TTM · consolidated
RETURN ON CAPITAL EMPLOYED
11.0%
TTM · consolidated
P/E
35.0x
Q4 FY26 · consolidated
EV/EBITDA
16.8x
Q4 FY26 · consolidated
EBITDA MARGIN
12.5%
TTM · consolidated
NET PROFIT MARGIN
8.6%
Q4 FY26 · consolidated
DEBT TO EQUITY
0.1x
Q4 FY26 · consolidated
Peers · Pharmaceuticals
As of Q4 FY26